Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer
- 1 March 2017
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 97 (3) , 516-525
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancerRadiation Oncology, 2014
- Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trialsRadiotherapy and Oncology, 2013
- Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 yearsRadiation Oncology, 2013
- Decision Regret in Men Undergoing Dose-Escalated Radiation Therapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Who makes the decision regarding the treatment of clinically localized prostate cancer–the patient or physician?Cancer, 2012
- High-Dose-Rate Monotherapy: Safe and Effective Brachytherapy for Patients With Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancerBJU International, 2011
- What Is Value in Health Care?New England Journal of Medicine, 2010
- Determinants of Treatment Regret in Low-Income, Uninsured Men With Prostate CancerUrology, 2008
- Satisfaction and Regret after Open Retropubic or Robot-Assisted Laparoscopic Radical ProstatectomyEuropean Urology, 2008